Premas Life Sciences Private Limited, a active private limited company, was established on 15 April 2011 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U51909DL2011PTC217592. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹28.73 Cr.
It upholds a compliant status. Employing 88 professional, Its leadership includes Debjit Patra (Director), Praveen Kumar Gupta (Managing Director), Avijit Das (Director). Past directors included Narahari Kousik, Debjit Patra, Praveen Kumar Gupta. It holds ₹132.00 Cr open charges and no settled loans. Its latest AGM occurred on 28 August 2024, with the balance sheet filed on 31 March 2024. It is based at Second Floor, E-49/5 Okhla Industrial Estate, Phase-Ii, New Delhi, Delhi, 110020.
U51909DL2011PTC217592
217592
15 April 2011
₹30.00 Cr
₹28.73 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Premas Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Debjit Patra | Director | 20 Mar 2016 | Current |
| Praveen Kumar Gupta | Managing Director | 15 Apr 2011 | Current |
| Avijit Das | Director | 15 Apr 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 14 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2016 | Past |
| Pramod Abcsdd | Director | 17 Jul 2018 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Premas Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.23% decrease. The company also saw a substantial fall in profitability, with a 45.23% decrease in profit. The company's net worth Soared by an impressive increase of 24.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Premas Life Sciences had a promoter holding of 93.12% and a public holding of 6.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,320,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2021 | Others | ₹27.00 Cr | Open |
| 29 Nov 2021 | Hdfc Bank Limited | ₹80.00 Cr | Open |
| 14 Mar 2019 | Citi Bank N.A. | ₹25.00 Cr | Open |
Explore comprehensive loan charge details -
Premas Life Sciences has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Premas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premas Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 80.00 Cr registered on 29 Nov 2021 with Charge ID 100504820 was modified on 26 Aug 2025. was recorded as a recent event.
Lakshika was appointed as a Company Secretary was appointed as a Company Secretary on 17 Apr 2025 & has been associated with this company since 7 months 16 days . was recorded as a recent event.
Premas Life Sciences Private Limited last Annual general meeting of members was held on 28 Aug 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others of Rs. 27.00 Cr registered on 22 Dec 2021 with Charge ID 100535456 was modified on 01 Jul 2024. was completed.
The activity Premas Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 14 Mar 2019 with Charge ID 100271765 was modified on 27 Jul 2023. was recorded as a recent event.
Premas Life Sciences Pvt Ltd PLS today announced that it has entered into a distribution agreement with Bionano a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine The agreement covers the distribution of Bionanos instruments chip consumables reagents and suite of data analysis tools in India Eventually this collaboration is expected to help sales and placements of Bionanos solutions in India.
The CIN of Premas Life Sciences Private Limited is U51909DL2011PTC217592.
Premas Life Sciences Private Limited is headquartered at Second Floor, E-49/5 Okhla Industrial Estate, Phase-Ii, New Delhi, Delhi, 110020.
Premas Life Sciences Private Limited was incorporated on 15 April 2011.
The current directors of Premas Life Sciences Private Limited are
The primary industry of Premas Life Sciences Private Limited is Professional, Scientific And Technical.
Premas Life Sciences Private Limited is unlisted.
The authorized capital of Premas Life Sciences Private Limited is ₹30.00 Cr, and the paid-up capital is ₹28.73 Cr.
The compliance status of Premas Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX